Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

9, 2024 — A study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by ...

The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 ...

TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- This May, Brain Cancer Canada (BCC) and communities across the country prepare to ...

In a recent study published in Small, researchers at the University of Michigan developed nanodiscs designed to target ...

Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas - ...

Novocure today announced that the U.S. Food and Drug Administration (FDA) approved the NovoTTF-100A System (NovoTTF) for the treatment of adult patients with glioblastoma multiforme (GBM) brain tumors ...

Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults ... professor of neurosurgery and a member of the Rogel Cancer Center. "Although surgery can help improve survival ...

Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Gliomas are a common type of malignant (cancerous) brain tumor. 1,2 A ...